Regulations on OTC Derivative Transactions and Reporting Requirements


Event Report

Mr. Mamoru Nakaya, Senior Deputy Director, FSA
Mr. Hironobu Akamatsu, Deputy Director, FSA
Mr. Takanori Naito, Deputy Director, FSA

Mr. Nakaya, Mr. Akamatsu, and Mr. Naito from the Financial Services Agency discussed regulatory framework under the recently promulgated Cabinet Office Ordinance on OTC Derivative Transactions including the requirement to report OTC derivative transactions. The presentation consisted of an overview of the regulations on OTC derivative transactions with a central focus on of the Cabinet Office Ordinance on Regulations on OTC Derivative Transactions, as well as the purpose and specific details of the OTC derivative transaction reporting requirement.

You must login to register for the event.